Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data by unknown
Köpcke et al. BMC Medical Informatics and Decision Making 2013, 13:134
http://www.biomedcentral.com/1472-6947/13/134RESEARCH ARTICLE Open AccessEvaluating predictive modeling algorithms to
assess patient eligibility for clinical trials from
routine data
Felix Köpcke1*, Dorota Lubgan2, Rainer Fietkau2, Axel Scholler3, Carla Nau3, Michael Stürzl4, Roland Croner5,
Hans-Ulrich Prokosch1 and Dennis Toddenroth1Abstract
Background: The necessity to translate eligibility criteria from free text into decision rules that are compatible with
data from the electronic health record (EHR) constitutes the main challenge when developing and deploying
clinical trial recruitment support systems. Recruitment decisions based on case-based reasoning, i.e. using past cases
rather than explicit rules, could dispense with the need for translating eligibility criteria and could also be imple-
mented largely independently from the terminology of the EHR’s database. We evaluated the feasibility of predictive
modeling to assess the eligibility of patients for clinical trials and report on a prototype’s performance for different
system configurations.
Methods: The prototype worked by using existing basic patient data of manually assessed eligible and ineligible
patients to induce prediction models. Performance was measured retrospectively for three clinical trials by plotting
receiver operating characteristic curves and comparing the area under the curve (ROC-AUC) for different prediction
algorithms, different sizes of the learning set and different numbers and aggregation levels of the patient attributes.
Results: Random forests were generally among the best performing models with a maximum ROC-AUC of 0.81
(CI: 0.72-0.88) for trial A, 0.96 (CI: 0.95-0.97) for trial B and 0.99 (CI: 0.98-0.99) for trial C. The full potential of this
algorithm was reached after learning from approximately 200 manually screened patients (eligible and ineligible).
Neither block- nor category-level aggregation of diagnosis and procedure codes influenced the algorithms’
performance substantially.
Conclusions: Our results indicate that predictive modeling is a feasible approach to support patient recruitment
into clinical trials. Its major advantages over the commonly applied rule-based systems are its independency from
the concrete representation of eligibility criteria and EHR data and its potential for automation.Background
Over the decades, the number of participants in numerous
clinical trials has frequently fallen short of expectations
[1-3]. When discrepancies between planned and actual
recruitment rates occur, trials need to be prolonged at
considerable cost or may even have to be aborted [4]. The
advent of electronic health records (EHR) and the increas-
ing volume of medical data contained within them have
raised the question whether and how these data can be
reused to improve the recruitment process of clinical* Correspondence: Felix.Koepcke@imi.med.uni-erlangen.de
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reproduction in any medium, provided the ortrials. In a recent literature review Cuggia et al. identified
28 different clinical trial recruitment support systems
(CTRSS) and found that ’all systems require the input of
both patient data and eligibility criteria’ [5]. The core
functionality of all CTRSS is the comparison of these two
inputs to evaluate whether a given patient suits the trial.
Unfortunately, trial protocols conventionally describe
eligibility criteria in free text, which cannot be directly ap-
plied to data in the EHR’s database. These criteria therefore
have to be encoded into a set of EHR-compatible rules,
a process which has proven difficult in practice. In an
analysis of 1000 randomly selected eligibility criteria, Ross
et al. [6] classified 85% of the criteria as semantically com-
plex. They conclude that ‘researchers trying to determineLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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biguous criteria as well as under-specified criteria requiring
clinical judgment or assessments.’
Weng et al. [7] found 27 different languages proposed
to represent eligibility rules in a computable format. They
distinguish ad hoc expressions, Arden Syntax, logic-based
languages, object-oriented query languages and temporal
query languages. More expressive languages can cover the
original meaning of the eligibility criteria, but become
more complex at the same time, resulting in a more tedi-
ous translation process. Still, none of the languages seems
to be able to accurately represent all eligibility criteria. Tu
et al. [8] estimate up to 60% criteria coverage for the ad
hoc expression language ERGO. Wang et al. [9] estimate
that their advanced Arden Syntax is able to describe up to
90% of all eligibility criteria. While complex languages for
eligibility rules representation have advantages in terms of
criteria coverage, they often rely on IT systems that are
uncommon in general practice and require a high level of
expertise. That this seems to limit adoption by other
clinics is underlined by the fact, that most CTRSS so far
relied on SQL statements to represent eligibility criteria.
Because of the difficulties with the manual translation
process, at least two research teams evaluated the feasibil-
ity of automatic encoding systems. Tu et al. [8] applied
natural language processing to transform 60 eligibility
criteria into ERGO expressions that were valid for 70% of
the criteria. Their method did however require manual
pre-processing. Lonsdale [10] applied syntactic parsing
and semantic conversion to transform 1545 eligibility
criteria into predicate logic expressions that were subse-
quently mapped to the hospitals data dictionary and trans-
lated to Arden Syntax. They succeeded in generating
queries for 520 (34%) criteria, though only half of these
queries proved to be completely correct or yield useful
information.
When it comes to transferring a CTRSS from the site
of development to another hospital, the main barriers are
due to differences in their information systems. Eligibility
rules developed in one hospital usually do not fit the EHR
of another because they make ‘certain assumptions about
the patient information model and terminology’ [8] and
because of different documentation conventions. There-
fore, the transfer of most of the existing CTRSS to other
hospital settings requires special knowledge and extensive
manual labor.
Objectives
In summary, the necessity to translate eligibility criteria
from free text into decision rules that are compatible
with the EHR data constitutes the main challenge when
developing and introducing CTRSS. An alternative to
this rule-based approach is case-based reasoning, which
relies on a knowledge base of past cases rather thanexplicit rules [11]. In the context of recruitment, a CTRSS
based on case-based reasoning could dispense with the
need for translating eligibility criteria and could also be
implemented independently from the terminology of the
EHR’s database. In this research, we implement such a
CTRSS using predictive modeling algorithms in order to
assess its feasibility for three clinical trials.
Methods
At Erlangen University Hospital, patient facts from the
21 most important clinical desktop applications are trans-
ferred to a relational data warehouse (DWH) on a daily
basis [12]. Patient age and gender are available from a
relational table, while diagnosis and procedure codes are
saved in entity-attribute-value (EAV) models. The code
system used for diagnosis codes is the ICD-10 German
Modification. For procedures, the ‘Operationen- und Pro-
zedurenschlüssel’ (OPS) catalogue, a German modification
of the International Classification of Procedures in Medi-
cine (ICPM), is used. The DWH can be queried for clin-
ical data of a patient using SQL. The cost-free statistics
software R version 2.14 was used for fitting and evaluating
the predictive models [13]. An off-the-shelf desktop com-
puter was used to run the software.
We suggest that in a productive environment, case-
based CTRSS would work as follows. When a new trial
is to be supported by the CTRSS, a set of patients is
manually screened. This could be either a one-time assess-
ment of a set of past patients or a continuous screening
process of patients as they enter the clinic. The eligibility
of each patient is documented in the EHR. When a certain
number of patients have been manually screened, the clin-
ical data of eligible and ineligible patients is extracted from
the EHR and used to derive a prediction model. The
model is saved and can be applied to predict the eligibility
of yet unscreened patients. The system thus proposes a list
of trial participants who are subsequently manually
assessed and their real eligibility entered in the EHR. With
increasing numbers of assessed patients, the model can be
continuously regenerated to improve its performance and
the manual screening can be reduced.
In order to evaluate the feasibility of this CTRSS, we
chose three clinical trials from different clinical depart-
ments of University Hospital Erlangen, which are briefly
presented in Table 1. The trials were chosen because each
featured a comparatively large number of local partici-
pants and a thorough screening process. The target of trial
A was to compare standards of peri-operative care and
outcome in 28 European countries [14]. Trial B validated
the ability of different biomarkers to predict colorectal
cancer stage, survival and response to chemo- and radio-
therapy. Finally, trial C investigated the effects of adding
oxaliplatin to standard combined modality treatment for
rectal cancer [15]. After obtaining approval from the data
Table 1 Brief description of the three clinical trials used to evaluate the feasibility of predictive modeling for eligibility
screening
Abbreviation Trial A
Full name European Surgical Outcome Study
Recruitment period 1 week, April 2011
Department Department of Anesthesiology
Inclusion criteria 1. older than 16 years
2. admitted for elective or non-elective inpatient surgery
Exclusion criteria 1. patients undergoing planned day-case surgery
2. patients undergoing cardiac surgery, neurosurgery, radiological or obstetric procedures
Abbreviation Trial B
Full name Sensitive polyprobe approach for improved prediction of therapy response and assessment of prognosis
in colorectal cancer
Recruitment period 3 years, December 2009 – December 2012
Department Department of surgery
Inclusion criteria 1. initial diagnosis of histopathologically confirmed colorectal cancer of UICC stage I-IV
Exclusion criteria 1. inflammatory bowel disease (Crohn’s disease, Ulcerative colitis)
2. hereditary tumor syndromes like Familial Adenomatous polyposis (FAP), Hereditary nonpolyposis colorectal
cancer (HNPCC)
Abbreviation Trial C
Full name Prospective Randomized Multicenter Phase-III-study: Preoperative Radiochemotherapy and Adjuvant Chemotherapy
With 5-Fluorouracil Plus Oxaliplatin Versus Preoperative Radiochemotherapy and Adjuvant Chemotherapy With
5-Fluorouracil for Locally Advanced Rectal Cancer
Recruitment period 3.5 years, July 2006 – February 2010
Department Department of Radiation Oncology
Inclusion criteria 1. aged 18 years or older
2. histopathologically confirmed rectal carcinoma with an inferior margin no more than 12 cm above the anal
verge, as assessed by rigid proctoscopy
3. evidence of perirectal fat infiltration (cT3–4) or lymph-node involvement (cN+), as assessed by endorectal
ultra sound, multislice CT, or MRI
4. Eastern Cooperative Oncology Group (ECOG) performance status 2 or lower
5. adequate hematological, liver, and renal function
Exclusion criteria 1. metastatic disease
2. prior radiotherapy or chemotherapy
3. other cancers
4. pregnancy or lactation
5. clinically significant cardiac disease
6. known peripheral neuropathy
UICC = Union for International Cancer Control, CT = X-ray computed tomography, MRI = Magnetic resonance imaging, CT3-4, cN+ = cancer stages according to
TNM staging system.
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view board that no formal vote was necessary for our
research, the principal investigator of each trial was
asked to provide a list of all patients included in the trial
until September 2012.
For each clinical trial, an SQL statement was used to
retrospectively query the DWH for the clinical data of
all patients treated by the corresponding department
during the trial’s recruitment phase. The query results
were anonymised, written to a text file and passed to R forfurther processing. To increase the general validity of our
evaluation, we restricted the data to those elements which
are found in virtually every hospital information system:
patient age and gender, as well as diagnosis and procedure
codes.
Since the DWH stored patient data in an EAV schema,
while predictive modeling algorithms as implemented in
R packages expect these attributes in the individual col-
umns of a tabulated dataset, an R function was deployed to
convert between these two storage models. One attribute
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procedure codes. Each attribute could assume one of two
values: Y if the code was ever found documented for the
patient and N if it was not. For example, if a patient had
the diagnosis code ‘A00.0’, he would have a value of ‘Y’ in
the column named ‘A00.0’.
Based on the review of predictive data mining algo-
rithms in clinical medicine by Bellazzi and Zupan [16]
we chose to compare the performance of the following
algorithms for predictive modeling: decision trees based
on the CART algorithm (as implemented in the R pack-
age rpart) [17], random forests by using decision trees
in conjunction with bootstrapping (resampling), logistic
regression with and without stepwise variable selection
(step function) and support vector machines (R package
e1071) [18].
Model fits were compared for different predictive algo-
rithms and parameter configurations by plotting receiver
operating characteristic (ROC) diagrams and assessing
the area under the curve (ROC-AUC) in a separate sub-
set of patients (holdout method with a test sample that
consisted of 33% of all patients). The ROC curve repre-
sents all possible combinations of specificity and sensi-
tivity for each predictive model, so ROC-AUC measures
its overall performance. The theoretical maximum ROC-
AUC value assumes 1 in case of perfect sensitivity and
specificity, while non-informative (random) predictions
would let ROC-AUC values converge to 0.5. ROC-AUC
values were complemented with 95% confidence limits
by generating 1,000 bootstrap resamples from each set
of prediction-observation-pairs and subsequently invoking
the quantile routine in conjunction with the resulting dis-
tribution of ROC-AUC values and probability parameters
of 2.5% and 97.5%.
Algorithms which require a smaller training set to
achieve a certain discriminatory power are preferable
insofar as they permit replacing the manual screening
process earlier. To gauge the dependency of system per-
formance on the size of the training set, we progressively
reduced the training data by iteratively discarding sub-
sets from the training sample and refitting predictive
models. With each iteration, approximately 30% of the
patients were randomly selected and removed from the
remaining training set.
Diagnosis and procedure codes are not independent
from each other, but adhere to a mono-hierarchical struc-
ture. Different levels of this hierarchy can be relevant to
decide between eligible and ineligible patients. Pregnant
patients, for example, are usually excluded from clinical
trials. During their stay at the hospital, this patient group
is likely to obtain one or more of 459 different ICD codes
beginning with the letter O. Unfortunately the standard
algorithms for predictive modeling lack the ability to take
such intrinsic connections between individual codes intoaccount. The size of the training set necessary to identify
for example a reproducible correlation between patient
eligibility and one of 459 individual attributes in chapter
O of the ICD catalogue could be substantially larger than
that necessary to find a correlation with the aggregated
attribute “catalogue chapter O”. Thus we assumed that
aggregating diagnosis and procedure codes could improve
the predictive quality of the models.
To test this hypothesis, we aggregated all diagnosis and
procedure codes in three steps: no aggregation leaves all
occurring codes as originally documented, category-level
aggregation reduces all codes to the third hierarchy level of
the corresponding catalogue and block-level aggregation
reduces all codes to its second hierarchy level. For ex-
ample, the procedure code 5–121.1 (incision of cornea
with laser) and the diagnosis code L40.4 (Guttate psoriasis)
would be reduced to 5–12 (corneal surgery) and L40 (Psor-
iasis) by category-level aggregation and to 5–08…5-16 (eye
surgery) and L40…L45 (Papulosquamous disorders) by
block-level aggregation. A patient was deemed affected by
one of the superordinate diagnostic or procedural classes if
any of the subordinate codes had been assigned to her.
For performance reasons, the number of diagnosis and
procedure codes passed to the predictive modeling algo-
rithms was limited following the aggregation process.
Two methods to reduce the number of codes were com-
pared: (1) taking the most frequently documented codes
and (2) taking those codes which were most strongly
associated with trial eligibility as measured by the chi-
squared test, or alternatively by Fisher's exact when the
data did not meet the frequency requirements for the
chi-squared test. All models were calculated for the first
20 and 40 codes selected by each method.
Results
When trial A was conducted previous to this study, 361
(70.6%) of 511 treated patients were manually included.
In the same way, 320 (3.9%) of 8170 patients visiting the
surgery department were included in trial B and 87
(1.6%) out of 5573 patients visiting the radiation oncol-
ogy were included in trial C. The diagnosis and proced-
ure codes which we extracted from the EHR assumed
2038 and 1648 (trial A), 5954 and 5816 (trial B) and
5052 and 5281 (trial C) different values respectively. The
number of distinct codes was similar for all three trials
after category-level aggregation (A: 1028, B: 1624, C: 1491
different codes) and block-level aggregation (A: 277, B:
302, C: 294 different codes). Each distinct code was repre-
sented by one column in the data set. Gender and age
were available for all patients. Patients without any diag-
nosis or any procedure code were the exception. Most
patients had several codes, although taken as a whole the
data tables were sparsely populated. Each of the distinct
diagnosis and procedure codes was documented for a
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1.6% after category-level aggregation and to 6.6% after
block-level aggregation. The numbers for all three trials
are summarized in Table 2.
Trial A excluded patients undergoing obstetric proce-
dures from inclusion. The 20 diagnosis and procedure
codes identified as most strongly associated with patient
eligibility mainly reflect this. For example, the original
diagnosis codes Z37.0 (single live birth), O82 (caesarean
section) and O09.6 (full term pregnancy) were included in
building the predictive model based on the originally doc-
umented codes. After block-level aggregation, ICD codes
for complications during pregnancy or birth (O20…O29,
O85…O99) and the OPS codes for obstetric procedure
(5-72…5-75) were additionally incorporated in the models.
However, the strong association of some codes like 5–50
(liver surgery) with eligibility is less obvious, as it is not
explicitly mentioned in the trial’s eligibility criteria. Liver
surgery is one of the procedures not excluded by the in-
clusion criteria of the trial. Patients with a liver surgery
were thus found to be more common in the set of trial
participants than in the set of non-participants and the
attribute is therefore associated with trial eligibility. The
lists showing the 20 attributes most associated with
eligibility are given for all trials and aggregation levels in
Additional file 1.
The ROC-AUC values generally improved with in-
creasing sizes of the training set. Neither category-level
nor block-level aggregation of diagnosis and procedure
codes led to a consistent influence on any of the models
based on the codes most associated with eligibility. Select-
ing the 20 most associated diagnostic codes generally out-
performed models based on the 20 most frequent codes,
but the differences decreased with increasing code aggre-
gation. Furthermore, there appeared to be no notable
difference between models based on 20 and 40 codes.
Figure 1 shows the ROC-AUC values for all 450 models
based on the 20 most associated codes. The figures for
the corresponding models based on the 40 most associ-
ated and on the 20 most frequent codes can be found in
Additional file 2: Figure S2 and Additional file 3: Figure
S3 respectively.Table 2 Data volume for the three clinical trials: number of p
period, number of patients included, number of attributes do





Number of attributes [n]/Valued cell
no. of codes)
[n] [n] [%] No aggregation Category-level a
A 511 361 70.6 3,689/0.7 1,031/1.9
B 8,170 320 3.9 11,773/0.3 1,627/1.6
C 5,573 87 1.6 10,336/0.4 1,494/2.1
Each different diagnosis and procedure code was treated as an independent patienThe following numbers are given for the best perform-
ing models, which were based on the most associated
codes without aggregation. After learning from 171 pa-
tients of trial A (33% of all patients), ROC-AUC reached
a maximum of 0.81 (CI: 0.72-0.88) for random-forest-
based predictions and did not increase further with
larger training sets. For smaller training sets, support
vector machines performed better than random forests,
achieving ROC-AUC values of up to 0.71 (CI: 0.61-0.79)
with a 60 patients (12%) training set. For trial B and C,
all algorithms showed high maximum ROC-AUC values
of up to 0.96 (CI: 0.95-0.97) and 0.99 (CI: 0.98-0.99) re-
spectively. Random forests and support vector machines
reached maximum performance early after learning from
only approximately 3% of all patients screened for trials
B and C, corresponding to 241 and 164 patients respect-
ively. This would correspond to 1 and 1.3 months of
manual screening of all admitted patients. Decision trees
and logistic regression models were susceptible to small
training sets and reached the other algorithms’ ROC-
AUC values only after including approximately 20% of
all patients. The complete numeric results including
confidence intervals are given in Additional file 4.
Discussion
The objective of this research was to evaluate the feasi-
bility of using predictive modeling for the identification
of potential participants of clinical trials. The major ad-
vantage compared to the currently predominant rule-
based approaches lies in the fact that the trial’s eligibility
criteria do not need to be translated into a computable
form. This allows the proposed system to be independ-
ent of the concrete representation of clinical data in a
specific hospital and thus to be easily applicable across
institutions. Furthermore, it capitalizes exclusively on
routine documentation and offers extensive scope for
automation.
Our results indicate that case-based CTRSS can be
suitable for practical implementation in clinical trials.
Predictive models based on random forests were gener-
ally among the best performing algorithms with ROC-
AUC values of up to 0.8 for one and of more than 0.95atients treated by the department during the recruitment
cumented for all these patients and the fraction of
s [%] (target variable, age, gender + Patients without any





Figure 1 Evaluation of the prototype’s performance for models based on age, gender and the 20 codes most associated with trial
eligibility: model fits were compared by area under the receiver operating characteristic (ROC) curve complemented with 95%
confidence limits (y-axis). Models were trained with differently sized training sets of patients (x-axis). All models were tested against one third
of the original patient set (hold-out method), thus the maximum size of the training set was two thirds of all patients. The experiment was done
for the original codes as documented, after aggregation to category level and after aggregation to block level.
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tential of this algorithm was reached for all three trials
after learning of about 200 manually screened patients
(eligible and ineligible). Thus the fraction of patients
who need to be screened manually is high for trials with
a low total number of patients to screen (33% in trial A)
and low for trials that require mass screening (3% in trial
B and C). For the latter, we believe our approach toconstitute a viable alternative to explicitly modeling
EHR specific rules for inclusion and exclusion criteria.
In addition to the size of the training set, theoretical
considerations indicate that the predictive performance
should also depend on the ratio of eligible to ineligible
patients. For example, if we considered the extreme case
of some hypothetical cohort with no (or all) patients
eligible, no associations between eligibility and other
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cluded within the predictive models. This suggests that
training sets with a more balanced distribution of eligible
and ineligible patients, all other things equal, should grad-
ually allow training better-discriminating predictive models.
Within our limited set of three investigated studies, how-
ever, other determinants such as the absolute size of the
training sample appear to have been more important.
We believe that the size of the training data set required
to obtain a useful predictive model is mainly dependent
on the properties and number of attributes which describe
the patients, but independent from the number of patients
required for the trial. Adding attributes can increase or
decrease the size of the training set that would be neces-
sary to attain the desired predictive ability. If additional
attributes are related to patient eligibility, they would most
likely contribute to decrease the number of patients that
require manual screening. Otherwise, these additional at-
tributes merely add noise (i.e. irreproducible associations)
to the dataset that must be accommodated by a larger set
of training data. The relationships between attribute selec-
tion and system performance will be object to further
investigation.
The right balance between sensitivity and specificity of
a CTRSS is trial-specific. Sensitivity will be favored if the
population of eligible patients is small, while a high spe-
cificity will be paramount, if the population is large [19].
Predictive modeling provides some flexibility with respect
to choosing among specificity and sensitivity constella-
tions by adapting probability thresholds according to trial
requirements. When sensitivity is important, specificities
of 0.25 [20] and 0.31 [19] may still be perceived positively
by their users. When the focus lies on specificity and the
trial’s eligibility criteria correspond well to the data ele-
ments in the EHR, rule-based CTRSS achieve a high spe-
cificity of up to e.g. 0.84 [21] and 0.96 - 1.0 [22]. For trials
B and C the prototype’s performance was similar to that
of these rule-based systems. For trial A however, the ROC
curves for the best performing predictive models allow
only for a specificity of about 0.4 for a fixed sensitivity of 1
after learning from one third of all patients. In contrast,
an SQL-based CTRSS, which was actually used to conduct
this trial at Erlangen University Hospital achieved nearly
100% sensitivity and specificity and could be employed
from day one [23]. On the one hand, the rule-based
CTRSS profited in this instance from a most favorable
choice of eligibility criteria that could be matched exactly
to EHR data elements. On the other hand, the predictive
modeling approach suffered from the relatively small size
of the learning set for trial A.
Our evaluation study is limited in that only a selected
subset of the available patient attributes was used to de-
rive the prediction models. While additional parts of the
clinical documentation such as laboratory results mayalso be usable in this context, we intentionally restricted
our analysis in order to obtain models that are primarily
straightforward and generalizable insofar as they build
on highly uniform data. The resulting models can obvi-
ously reflect the original eligibility criteria only to the ex-
tent that there are corresponding associations in the data.
In principle though, every hospital can incorporate data
elements from its proprietary documentation, for example
laboratory, medication and assessment form data, to in-
crease the system’s accuracy. This would not require any
modification in the method for data analysis and prepar-
ation other than the inclusion of additional data tables
from the EHR.
Though the early results of the prototype are encour-
aging, we see a number of potential enhancements that
future research could investigate. First, the temporal
aspects of and relationships between patient attributes
were not regarded during data collection and the model-
ing process. Incorporating temporal information could
be important for a subset of clinical trials that require
events to appear in a specific order or in a given time-
frame. Second, free text data have been shown to contain
information that is relevant for the purpose of eligibility
assessment [24-26]. So far the prototype only supports nu-
meric attributes and attributes with pre-defined value lists.
Zhang et al. recently reported on their subtree match
method, which finds structural patterns in free text sen-
tences and thus allows to find similar sentences in other
documents [27]. Both the list of keywords and their gram-
matical structure can be automatically derived from the
text. We believe this approach could be further enhanced
to allow the inclusion of small text fragments into the
predictive modeling process. Third, both the case-based
and the rule-based CTRSS are heavily dependent on the
completeness and correctness of the EHR’s clinical data.
Further studies should also compare the robustness of
case-based and rule-based CTRSS for missing data and in-
correct data. We hypothesize that case based systems are
more insensitive to missing data, because they are based
on a broader base of data elements and more sensitive to
incorrect data as these cause imprecise prediction models.
Within multicenter trials, the prediction model gener-
ated by one site could be distributed to the others only if
they share a common terminology. For example, the
models developed in this feasibility study are restricted
to hospitals using the ICD-GM and OPS catalogues. The
wish to share the same predictive model with each other
would inhibit all participating institutions to use the
wealth of potentially relevant patient data encoded in a
proprietary terminology. This dependency on EHR termin-
ologies is however not restricted to case-based reasoning,
but restricts the distribution of rule-based CTRSS and clin-
ical decision support systems in general in the same way
[28]. Including institution-specific attributes in the analysis
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the CTRSS. In this case, predictive learning has an import-
ant advantage over explicit rules: new institution-specific
prediction models can be trained automatically without
having to analyze the EHR data elements regarding their
meaning and usage by the intervention clinic in order to
specify the relevant data elements. While the meaning of
the data is of decisive importance where rules are to be
developed, it is irrelevant to train the predictive model.
Additionally, the setup of the case-based system itself
requires only the extraction and formatting of all available
patient data from the EHR.
Conclusions
Case-based reasoning constitutes a viable alternative to
the widely applied rule-based approach to reusing med-
ical records for patient recruitment and can be success-
fully implemented using predictive modeling algorithms.
For two out of three evaluated trials system performance
was comparable with results published for rule-based sys-
tems even though a technically simple approach was used
in the prototype. The case-based CTRSS offers many ad-
vantages, namely its independence from the trial protocol’s
definition of eligibility criteria and from the terminology of
the clinical database. Future investigations might delineate
advantages and disadvantages of the approach when com-
pared to rule-based methods in particular.
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